Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$28,787,156
+$5,695,488 QoQ
Shares Held
191,876
-23.2% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#95
of 594 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $119,494,638 across 9 Diagnostics & Research names. GH ranks #1 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
191,876 | $28,787,156 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
116,144 | $26,340,297 | |
| 3 | NTRA |
Natera, Inc.
|
76,415 | $20,742,851 | |
| 4 | A |
Agilent Technologies, Inc.
|
107,654 | $14,299,680 | |
| 5 | RDNT |
RadNet, Inc.
|
202,005 | $12,457,648 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
16,776 | $8,410,815 | |
| 7 | WAT |
Waters Corp /De/
|
20,721 | $7,771,203 | |
| 8 | ILMN |
Illumina, Inc.
|
2,746 | $482,829 |
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,787,156 | 191,876 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $23,091,668 | 249,991 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $16,243,222 | 159,029 | Shares | Sole | 2026-02-11 | |
| 2021-09-30 | $2,523,951 | 20,190 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $4,078,399 | 32,840 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,462,865 | 22,685 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||